Φορτώνει......
Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
Omecamtiv mecarbil is a selective, small-molecule activator of cardiac myosin that is being developed as a potential treatment for heart failure with reduced ejection fraction. Here we determine the crystal structure of cardiac myosin in the pre-powerstroke state, the most relevant state suggested b...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Nat Commun |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Nature Publishing Group UK
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5543065/ https://ncbi.nlm.nih.gov/pubmed/28775348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-017-00176-5 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|